Decker Retirement Planning’s iShares Biotechnology ETF IBB Stock Holding History

Decker Retirement Planning’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.9M	Buy	+56,424	New	+$11.3M	3.94%	6

Other funds holding IBB

Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return

Equitable Trust Nashville, Tennessee $2.38B AUM 22.38% 1-Year Est. Return

Decker Retirement Planning's IBB Position: Q3 2026 in Review

Decker Retirement Planning opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 56,424 shares worth $11.9M. The stake represents 3.94% of the portfolio and ranks #6 among its holdings.

190 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

Decker Retirement Planning held 56,424 shares of iShares Biotechnology ETF worth $11.9M as of Q3 2026.
iShares Biotechnology ETF was a new Decker Retirement Planning position in Q3 2026.
iShares Biotechnology ETF made up 3.94% of Decker Retirement Planning's portfolio in Q3 2026, its #6 holding.
190 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Decker Retirement Planning's 13F filing for Q3 2026, filed 19 Oct 2026.